BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Türk T, Pirildar T, Tunç E, Bor S, Doğanavşargil E. Manometric assessment of esophageal motility in patients with primary Sjögren's syndrome. Rheumatol Int 2005;25:246-9. [PMID: 14722732 DOI: 10.1007/s00296-003-0426-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Allen JE, Belafsky PC. Otolaryngologic Manifestations of Sjögren’s Syndrome. In: Fox RI, Fox CM, editors. Sjögren’s Syndrome. New York: Springer; 2012. pp. 269-83. [DOI: 10.1007/978-1-60327-957-4_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Qureshi A, Jehangir A, Malik Z, Parkman HP. Rheumatologic disorders in patients undergoing esophageal manometry: prevalence, symptom characteristics, and manometric findings. Dis Esophagus 2021;34:doaa135. [PMID: 33558877 DOI: 10.1093/dote/doaa135] [Reference Citation Analysis]
3 Park K, Haberberger RV, Gordon TP, Jackson MW. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome. Arthritis & Rheumatism 2011;63:1426-34. [DOI: 10.1002/art.30282] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
4 Park K, Park S, Jackson MW. The inhibitory effects of antimuscarinic autoantibodies in the sera of primary Sjogren syndrome patients on the gastrointestinal motility. Molecular Immunology 2013;56:583-7. [DOI: 10.1016/j.molimm.2013.06.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
5 Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol 2012;46:25-30. [PMID: 22157220 DOI: 10.1097/MCG.0b013e3182329d9c] [Cited by in Crossref: 64] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]
6 Bektas M, Seven G, Idilman R, Yakut M, Doğanay B, Kabacam G, Ustun Y, Korkut E, Kalkan Ç, Sahin G, Cetinkaya H, Bozkaya H, Yurdaydin C, Bahar K, Cinar K, Soykan I. Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis. Eur J Intern Med 2014;25:230-4. [PMID: 24534163 DOI: 10.1016/j.ejim.2014.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Savarino E, de Bortoli N, Bellini M, Galeazzi F, Ribolsi M, Salvador R, Savarino V, Penagini R. Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement. Dig Liver Dis 2016;48:1124-35. [PMID: 27443492 DOI: 10.1016/j.dld.2016.06.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
8 Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity. Arthritis Res Ther 2017;19:237. [PMID: 29065905 DOI: 10.1186/s13075-017-1446-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
9 Craig E, Cappelli LC. Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis. Rheum Dis Clin North Am 2018;44:89-111. [PMID: 29149929 DOI: 10.1016/j.rdc.2017.09.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
10 Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT. Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome. Scand J Rheumatol 2007;36:394-401. [PMID: 17963171 DOI: 10.1080/03009740701607638] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
11 Sakakibara R. Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions. Auton Neurosci 2021;232:102795. [PMID: 33740560 DOI: 10.1016/j.autneu.2021.102795] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Eyigör S. Dysphagia in rheumatological disorders. World J Rheumatol 2013; 3(3): 45-50 [DOI: 10.5499/wjr.v3.i3.45] [Cited by in CrossRef: 6] [Article Influence: 0.7] [Reference Citation Analysis]
13 Galli J, Marchese MR, De Canio C, Di Salvo M, Olivieri I, Santandrea L, Paludetti G. The prevalence of dysphonia and dysphagia in patients affected by immunomediated diseases and the role of psychometric tests. Clin Rheumatol 2019;38:77-84. [PMID: 29728930 DOI: 10.1007/s10067-018-4129-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE. Gastrointestinal Manifestations of Rheumatological Diseases. Am J Gastroenterol 2019;114:1441-54. [PMID: 31205138 DOI: 10.14309/ajg.0000000000000260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
15 Khalaf M, Castell D, Elias PS. Spectrum of esophageal motility disorders in patients with liver cirrhosis. World J Hepatol 2020; 12(12): 1158-1167 [PMID: 33442445 DOI: 10.4254/wjh.v12.i12.1158] [Reference Citation Analysis]